Vestal Point Capital, LP 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 2:35 pm Purchase | 2024-12-31 | 13G | Applied Therapeutics, Inc. APLT | Vestal Point Capital, LP | 11,500,000 9.900% | 10,355,000 (+904.37%) | Filing |
| 2024-11-14 12:00 pm Sale | 2024-09-30 | 13G | Applied Therapeutics, Inc. APLT | Vestal Point Capital, LP | 1,145,000 1.000% | -3,010,000 (-72.44%) | Filing |
| 2024-02-13 4:34 pm Purchase | 2023-12-31 | 13G | Applied Therapeutics, Inc. APLT | Vestal Point Capital, LP | 4,155,000 5.400% | 4,155,000 (New Position) | Filing |